INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.
-
(2012/03/10)
INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS
Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
-
Page/Page column 28
(2010/11/28)
INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS
-
-
(2010/02/12)
More Articles about upstream products of 76536-99-7